| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-06 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |